Moreover, DBP-maf have been reported to inhibit angiogenesis and tumor growth in mice [103] and to inhibit VEGF signaling by decreasing VEGF-mediated phosphorylation of VEGF-2 and ERK1/2, a downstream target of the VEGF signaling cascade [104]. The gene discussed is VEGFA; the disease is neoplasm.